Founded
Address
Bay City Capital LLC
750 Battery Street
Suite 400
San Francisco, CA 94111
United States
Phone
Website
Recent investment activity
KANDO id: 2637
Corporate information
Registration country
Funding rounds
Actual initial investment stage
N/A (1)
Investment activity status
Active investor
Selected investments
Displaying 26 - 50 of 64| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Maxia Pharmaceuticals Inc | Formed to exploit the non-dermatological applications of a patented library of compounds licensed from Galderma. | N/A | |||
|
|
Medarex Inc | Creates and develops therapeutic products for cancer, autoimmune disease and other life-threatening and debilitating diseases. | N/A | |||
|
|
Merus Biopharmaceuticals BV | Dutch antibody company focused on the use of two proprietary technologies to build a pipeline of innovative human therapeutic antibodies: the Oligoclo | N/A | |||
|
|
Metabolex Inc | Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. | N/A | |||
|
|
Metabolex Inc | Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. | Series D | |||
|
|
Nevro Corp | Medical device company marketing novel neuromodulation therapies for the treatment of chronic, intractable pain. | N/A | |||
|
|
Nevro Corp | Medical device company marketing novel neuromodulation therapies for the treatment of chronic, intractable pain. | Series A | |||
|
|
Nexus Dx Inc | N/A | ||||
|
|
Oculex Pharmaceuticals Inc | A drug discovery and specialty pharmaceutical company developing products based on a proprietary intraocular drug delivery system. | N/A | |||
|
|
Omegatech | Develops and sells products from microalgae. | N/A | |||
|
|
Panomics Inc | Develops novel cell-based assays and tools to enable multiplexed measurements of molecular events in a quantitative and scalable manner | N/A | |||
|
|
Pathway Diagnostics Corp | A full-service biomarker assay development and commercialization company that uniquely combines expertise in clinical biomarker diagnostics with acces | N/A | |||
|
|
Pharmion Corp | Initially, Pharmion concentrated its efforts on licensing products in the areas of hematology, oncology and supportive care. | N/A | |||
|
|
Poniard Pharmaceuticals Inc | Develops and commercializes oncology products. | N/A | |||
|
|
Presidio Pharmaceuticals Inc | Drug discovery and development, focused on anti-viral indications | N/A | |||
|
|
Presidio Pharmaceuticals Inc | Drug discovery and development, focused on anti-viral indications | Series B | |||
|
|
Protez Pharmaceuticals Inc | Developer of a small molecule antibiotics to address increasing bacterial resistance and chronic or recurrent infections. | N/A | |||
|
|
PTC Therapeutics Inc | Biopharmaceutical company. | N/A | |||
|
|
Reliant Pharmaceuticals Inc | American heart drug specialist company. | N/A | |||
|
|
ReSet Therapeutics Inc | N/A | ||||
|
|
Senomyx Inc | Discovery and development of innovative flavor ingredients for the food, beverage, and ingredient supply industries | N/A | |||
|
|
Sunesis Pharmaceuticals Inc | Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and he | N/A | |||
|
|
SynGen Inc | Develops products that utilize single-use sterile plastic cartridge disposables mated to dedicated, highly automated electromechanical medical devices | N/A | |||
|
|
Syntonix Pharmaceuticals Inc | A needle-free drug delivery company utilizing the FcRn receptor to transport macromolecules across epithelial barriers in the central airway and into | N/A | |||
|
|
Syrrx Inc | Combines high-throughput structure determination, HTS, combinatorial and medicinal chemistry together with computational methods to discover novel sma | N/A |